Li, Wei
Wang, Yongyi
Huang, Ritai
Lian, Feng
Xu, Genxing
Wang, Weijun
Xue, Song
Funding for this research was provided by:
Shanghai Science and Technology Development Foundation (SY20221RUE01)
Article History
Received: 18 May 2023
Accepted: 1 February 2024
First Online: 9 February 2024
Declarations
:
: This study was approved by the Shanghai Jiaotong University School of Medicine, Renji Hospital Ethics Committee (KY2021-159-B), and complied with the principles set forth by the Declaration of Helsinki. All participants or their guardians were aware of the purpose, risks and rights of this research. Their personal safety and health rights have been fully guaranteed. All participants were free to withdraw at any time, and their treatment activities were not affected by the withdrawal. Informed consent was signed by all participants. The researchers followed the requirements of the GCP and ethical laws and regulations and strictly followed the approved protocols and documents to carry out this clinical study. All research involving human genetic resource activities was approved/recorded by the Office of Human Genetics and carried out after the start of ethical approval.
: The manuscript does not involve any identifiable images or data. Consent for publication is not applicable.
: The authors declare no competing interests.